[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
789
Current
205
To be discontinued
196
Flagged unavailable
20% flagged unavailable · latest update 2026-07-27 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,166 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Etomidate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2022-10-05
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyUnavailableCurrent2018-09-05
Liraglutide InjectionInjectionHikma Pharmaceuticals USA, Inc.Endocrinology/MetabolismAvailableCurrent2023-07-18
Lidocaine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2018-06-13
Midazolam Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2020-04-02
Etomidate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2022-10-05
Sodium Acetate InjectionInjectionHikma Pharmaceuticals USA, Inc.Endocrinology/MetabolismUnavailableCurrent2016-02-03
Midazolam Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2020-04-02
Meperidine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2025-05-30
Liraglutide InjectionInjectionHikma Pharmaceuticals USA, Inc.Endocrinology/MetabolismAvailableCurrent2023-07-18
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyLimitedCurrent2018-09-05
Promethazine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2023-11-21
Lisdexamfetamine Dimesylate CapsuleCapsuleHikma Pharmaceuticals USA, Inc.PsychiatryLimitedCurrent2023-07-14
Bumetanide InjectionInjectionHikma Pharmaceuticals USA, Inc.CardiovascularAvailableCurrent2018-01-31
Fentanyl Citrate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2023-12-20
Ketorolac Tromethamine InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionUnavailableCurrent2018-06-06
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyUnavailableCurrent2018-09-05
Etomidate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2022-10-05
Propranolol Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.CardiovascularUnavailableCurrent2023-10-31
Lisdexamfetamine Dimesylate CapsuleCapsuleHikma Pharmaceuticals USA, Inc.PsychiatryLimitedCurrent2023-07-14
Promethazine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionUnavailableCurrent2023-11-21
Sodium Acetate InjectionInjectionHikma Pharmaceuticals USA, Inc.Endocrinology/MetabolismAvailableCurrent2016-02-03
Etomidate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2022-10-05
Dopamine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.CardiovascularUnavailableCurrent2017-11-06
Ketorolac Tromethamine InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionUnavailableCurrent2018-06-06
Page 25 of 47
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).